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I: LITERATURE OVERVIEW 
1 INTRODUCTION   
 
The enteric nervous system (ENS) is a network that consists of neurons and glial cells 
that innervate the gastrointestinal tract (GIT) (As reviewed in Furness et al. 2014). 
Unlike other peripheral organs, the GIT has extensive intrinsic innervation from the 
ENS. In humans, there are 200 - 600 million enteric neurons, more than all neurons in 
sympathetic and parasympathetic ganglia combined and equivalent to the number of 
neurons in the spinal cord. In resemblance to the central nervous system (CNS), the 
ENS has many phenotypically different neurons and most, if not all, of the same 
neurotransmitters (As reviewed in McConalogue and Furness 1994). 
The ENS is considered its own autonomic division; the neurons in the ENS form 
circuits that regulate secretion, gut motility, hormone release, the movement of fluids 
across the epithelium, local blood flow, modification of nutrient handling, and 
communication with the immune and endocrine systems of the gut ( As reviewed in  
Furness et al. 2014). In old textbooks, the autonomous nervous system (ANS) is 
depicted as efferent pathways that consist of preganglionic neurons and postganglionic 
neurons, and afferent sensory neurons that travel to the CNS through spinal and cranial 
nerve pathways. In the ENS, however, there are intestinofugal neurons that have their 
cell bodies in enteric ganglia, that project to the sympathetic ganglia, pancreas, 
gallbladder and trachea. The neuronal control of the GIT is a combination of 
interactions between local reflexes, reflexes that go through sympathetic ganglia, and 
reflexes that go through the CNS. In other words, the ENS is connected to the CNS, but 
it can also regulate gut functions independently, hence the term “the second brain.”  
The ENS plays different roles in different part of the GIT ( As reviewed in Furness et al. 
2014). For example, neuronal control of the esophagus is largely controlled by the CNS. 
Even though the ENS has extensive innervation in the esophagus, its role is secondary 
to the CNS. The propulsion of the stomach is largely myogenic, but the CNS controls it. 
On the other hand, the ENS has more distinctive role in the small intestine and the colon 
(except for defecation). The CNS is connected to the ENS through the vagal, 
sympathetic and pelvic pathways.  The vagus nerve innervates the distal small intestine 
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and the proximal colon to a lesser extent than the esophagus, the stomach and the 
proximal small intestine. 
Hirschsprung’s disease (HSCR) is a congenital disorder where the ENS is missing from 
the distal intestine at birth (As reviewed in Kenny et al. 2010). To understand its 
pathophysiology, knowledge about the structure of the gastrointestinal wall and how the 
ENS develops and is embedded is necessary. As we will discuss in more detail below, 
the GIT is comprised of functionally different layers and many different cell types 
(Figure 1).  
The mucosa is the inner most layer in direct contact with the lumen ( As reviewed in 
Yoo and Mazmanian 2017). The mucosa is composed of mucus, a single layer of 
epithelial cells, and the lamina propria. The mucus that is produced mostly by 
specialized cells in the epithelium called goblet cells covers the epithelium and protects 
it from invading pathogens. The single layer of epithelial cells in the gut is a 
heterogenous group of cells. In addition to goblet cells, the other common cell types are 
enterocytes, enteroendocrine cells, Paneth cells, and M cells. Enteroendocrine cells 
produce hormones when activated by various stimuli in the gut; these hormones can 
regulate gut functions such as motility and secretion. Paneth cells have a role in 
epithelial stem cell maintenance and  they can also produce antibacterial compounds 
that protect host from invading pathogens. However, the most common cell type in the 
epithelium are enterocytes, primarily responsible for nutrient handling. Most of the 
nutrients are absorbed in the promixal parts of the gut where the epithelium is arranged 
in protruding tip-like structures called villi that maximize the surface area for absorption 
(As reviewed in Kiela and Ghishan 2016). Although water and NaCl are absorbed in the 
colon, there are no villi and minimal absorption of nutrients in the colon. Absorbed 
nutrients diffuse into the lamina propria, the prominently vascularized space underneath 
epithelial cells, and are transported to other locations of the body. The lamina propria is 
connective tissue that supports the structure of the epithelium, and it is home to many 
different types of immune cells that regulate the immune response of the GIT ( As 
reviewed in Yoo and Mazmanian 2017).  
Underneath the mucosa lies the submucosa separated by thin layer of smooth muscle 
cells ( As reviewed in Yoo and Mazmanian 2017). In the submucosa, there are 
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submucosal neurons arranged in the plexus that regulate the secretion of the fluids and 
GI blood flow.  
GI motility is generated by the muscularis propria, two distinct layers of smooth muscle 
cells (circular and longitudinal), and myenteric neurons that regulate their contraction ( 
As reviewed in Yoo and Mazmanian 2017). The serosa, which is part of the membrane 
that lines the abnominal cavity lubricates the GI and is the outer most layer that is 
adjacent to the mesentery. Extrinsic fibers innervate the gut either directly or indirectly 
via enteric ganglia. 
 
Figure 1. The structure of the GI wall. The GI wall consists of functionally different 
layers. The epithelium is mainly composed of enterocytes, but other cell types exist, 
such as, the enteroendocrine cells (EEC), the Paneth cells, the goblet cells and the M 
cells. The epithelium is covered by mucus which is primarily produced by goblet cells 
although other cell types can produce mucin. Enteric neurons are organized in two 
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distinct networks called the submucosal and myenteric plexus. Besides neurons, both 
plexuses have a great number of enteric glial cells that support these neurons and 
provide nutrients. Being exposed to number of bacteria, the gut is immunologically very 
active, and a number of different immune cells exist in the lamina propria and in the 
muscularis as depicted (Modified from Yoo and Mazmanian 2017).  
The contraction of the smooth muscle tissue in the gut is driven by excitatory motor 
neurons that use acetylcholine (cholinergic motor neurons) as a primary 
neurotransmitter (As reviewed in Hansen 2003). Inhibitory motor neurons responsible 
for the relaxation of the smooth muscle tissue primarily use nitric oxide (nitrergic motor 
neurons). However, motoneurons co-express neuromodulators, such as neuropeptides, 
that also participate in the regulation of gut motility. Intrinsic primary sensory neurons 
(IPANs) form synapses with both excitatory and inhibitory enteric neurons directly or 
indirectly via interneurons (Figure 2 ). Among other stimuli, luminal distension and 
serotonin released from enterochromaffin cells (ECs), a special type of enteroendocrine 
cells storing around 95% of the total serotonin in the human body, can activate IPANs 
(As reviewed in Gershon and Tack 2007). Concurrent activation of both excitatory and 
inhibitory enteric neurons underlies the “peristaltic reflex” or “the law of the intestine” 
which was originally described by Bayliss and Starling in 1899 (Bayliss and Starling 
1899). This is the movement of the content via oral contraction behind the bolus and 
anal relaxation in front of it. However, other researchers have had difficulties showing 
that local stimulation would lead to these previously theorized coupled contraction and 
relaxation patterns (Spencer et al. 1999).  
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Figure 2. Peristaltic reflex. Intrinsic primary sensory neurons (IPANs) can be activated 
by luminal distension or by serotonin released from ECs. The contraction occurs when 
IPANs stimulate orally situated ascending interneurons or excitatory motor neurons 
directly. The contraction is mediated primarily by release of acetylcholine (ACh). 
Simultaneously, IPANs synapse with descending interneurons or directly with 
inhibitory motor neurons that cause the relaxation of anally situated muscle, mediated 
primarily by nitric oxide (NO), thereby reducing the intraluminal pressure (Modified 
from Rao and Gershon 2016).  
 
 
2 Hirschsprung’s disease (HSCR) 
 
Hirschsprung’s disease (HSCR) is the most common congenital disease affecting 
intestinal motility ( As reviewed in  Kenny et al. 2010). HSCR is characterized by a 
complete lack of enteric neurons (aganglionosis) typically in the distal colon. The lack 
of the ENS results in intestinal obstruction leading to a failure to thrive (Stewart and 
von Allmen 2003). While historically HSCR was fatal, nowadays babies suffering from 
HSCR have their aganglionic segment surgically removed. 
HSCR can be divided into either short-segment or long-segment HSCR depending on 
the length of the aganglionic segment (As reviewed in  Kenny et al. 2010). In short-
 7 
 
segment HSCR, which represents 80% of HSCR cases, the aganglionic segment is 
restricted to the most distal segment of colon called the rectosigmoid region. In long-
segment HSCR, the aganglionic segment is more variable and may extend to the small 
intestine in some rare cases (As reviewed in Stewart & von Allmen 2003). The 
prevalence of HSCR is 1:5000, and there might be differences in ethnical populations 
(As reviewed in Kenny et al. 2010).  
Mutations in RET, a receptor tyrosine kinase for members of the glial cell line-derived 
neurotrophic factor (GDNF) family ligands, is overwhelmingly the biggest risk factor in 
HSCR; a coding mutation is found in 48% of familial cases and in 20% of sporadic 
cases (As reviewed in Heuckeroth 2018). Also, a non-coding RET variant in which a 
conserved enhancer-like sequence in intron 1 in RET is mutated increases the risk of 
HSCR significantly (Emison et al. 2005). The proper development of the enteric 
nervous system relies on molecular mechanism that govern survival, proliferation, 
migration, and differentiation of the enteric neuron precursor cells (As reviewed in 
Young and Newgreen 2001). RET-signalling plays an extremely important role in all 
those aspects. Therefore, factors that weaken RET-signalling increase the risk of 
developing HSCR. For example, RET heterozygosity increases the risk of HSCR by 
3000-fold (As reviewed in Heuckeroth 2018). Transcription of RET is regulated by 
genes like SOX10 and PHOX2B, and, indeed, 4% and 0.5% HSCR cases respectively 
have mutations in these genes. Mutations in endothelin receptor B (ENDRB), also 
important for ENS development, accounts for 5% of all HSCR cases and is the second 
most common genetic risk factor for HSCR. It should be noted that HSCR can be part 
of a syndrome like Trisomy 21 (Down syndrome) or Waardenburg syndrome. Indeed, 
8% of HSCR patients have trisomy 21. In trisomy 21, the whole chromosome including 
the genes on chromosome 21, many of which are associated with HSCR, are triplicated, 
leading to an approximately 50% increase in gene dose. One of these genes is collagen 
IV, which can inhibit migration of neural crest cells at higher levels. 
Interestingly, 80% of all HSCR patients are male. Sex-determining region Y protein 
found on the Y chromosome has a binding site on a RET regulatory element, and it 
competes with SOX10, an essential transcription factor in the ENS development. 
Animal studies have also shown that levels of END3 and ECE1, parts of endothelin 
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signalling, are found to be lower in male mice than in female mice, perhaps explaining 
part of the increased risk of developing HSCR in males.   
Although HSCR has a superficially simple cause, the lack of ENS innervation, it has a 
complex genetic aetiology (As reviewed in Heuckeroth 2018). Even with modern 
clinical genetic testing, including exome sequencing, gene panels, and single nucleotide 
polymorphism (SNP) analysis, it is only possible to identify disease causing variants in 
half of the children that have HSCR leaving the other half of the HSCR cases 
unexplained. Currently, low-penetrance risk alleles combined with environmental 
factors during fetal development are thought to contribute to HSCR pathogenesis in 
cases where no known risk variants are found. Thus, diagnosis of HSCR poses a 
challenge.   
  
 
2.1 Symptoms, diagnosis and treatment 
 
Due to impaired intestinal motility, infants may have constipation, emesis, abdominal 
pain or distention, and, in some cases, diarrhea (As reviewed in Parisi 1993). Failure to 
pass meconium within the first 48 hours after the birth occurs in 50%-90% of newborns 
with HSCR. Most infants affected by HSCR have gut-related symptoms during the first 
two months of their life.  In some cases, HSCR is diagnosed later in childhood or in 
even adulthood, and severe constipation lasting throughout life might indicate HSCR. 
The most life-threatening symptom is HSCR-associated enterocolitis (HAEC), which 
occurs approximately in 30% of the short segment cases and in 50% of the long 
segment cases (Frykman and Short 2012; Murphy and Puri 2005). 
The definitive diagnosis of HSCR requires suction biopsy followed by histological 
analysis to show the absence of enteric ganglia (As reviewed in Parisi 1993). 
Supporting diagnostic tests include anorectal manometry, abdominal radiographs that 
can show the empty rectum and dilated proximal colon.  
Routine treatment for HSCR is a surgical operation called “pull through” (As reviewed 
in Parisi 1993). In pull through, the aganglionic segment is resected, and the remaining 
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ganglionic segment is joined to the anus. Pull through operation is a highly successful 
operation, yet after surgery complications do occur; constipation and diarrhea are 
frequent, and HAEC is still common even after successful surgery (As reviewed in 
Heuckeroth 2018). 
 
 
2.3 Hirscprung’s disease associated enterocolits (HAEC) 
 
Hirschsprung’s disease associated enterocolitis or HAEC is the most fatal complication 
of HSCR and the most common cause of mortality and morbidity in neonates, is 
characterized by abdominal distension, fever, foul smelling stool, explosive diarrhea, 
and eventually sepsis and death if left untreated (As reviewed in Frykman and Short 
2012; Pini Prato et al. 2011). HAEC can develop relatively suddenly, and its incidence 
seems to be unperturbed by surgical intervention both in humans and in animal models 
(Marty et al. 1995; Polley et al. 1985; Zhao et al. 2010). The aetiology of HAEC is 
poorly understood with several different, mutually non-exclusive theories proposed. 
Those theories can be roughly divided in three groups: impaired mucosal function, 
immune dysfunction and microbiome dysbiosis, reviewed in (As reviewed in Austin 
2012), which I will briefly describe below. 
 
 
2.3.1 Structure of the mucosa 
 
The intestinal epithelium is covered by mucus (Johansson et al. 2008; as reviwed in 
Johansson and Hansson 2016). While the small intestine has a single, detachable mucus 
layer, the colon has two layers; one of which, the inner layer, is tightly attached to the 
epithelium. The single mucus layer of the small intestine is not impenetrable to bacteria, 
and invaders are kept away by means of antibacterial molecules. Crypts have the 
highest concentration of antibacterial compounds mostly produced by Paneth cells 
residing at the crypt bottom. Paneth cells are only found in the small intestine  (As 
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reviewed in Mowat and Agace 2014). In the colon however, while the inner layer is 
impenetrable, the outer layer is penetrable and expanded, allowing bacteria to reside 
there (Johansson et al. 2008). In mouse caecum, the pouch-like structure considered the 
beginning of the colon where fermentation occurs, bacteria are in contact with the 
epithelium. This is not the case in the rest of the colon. The colon absorbs water and 
NaCl, which leaves the compact fecal material of micro-organisms and undigested fiber 
to mechanically stress the epithelium and simultaneously expose micro-organisms to it. 
Endogenous proteases cleave mucins in the inner layer, allowing their movement to the 
outer layer, lessening mucin density. This serves an important function; mucins can now 
cover fecal material and travel with it and micro-organisms in the outer layer. Because 
there is a lot of water in the mucin network, compounds do not diffuse away from it 
easily. Mucins are abundant in the small intestine and colon. In the small intestine, 
mucin-producing goblet cells are mainly found in crypts, but some can be found among 
enterocytes on the villi. In the colon, goblet cells are mostly found in upper parts of the 
crypt, and they are filled with large mucus granulae. 
Major components in mucus are gel like glycoproteins called mucins that are highly o-
glycosylated; more than 50% of mucin mass comes from o-glycans (As reviewd in 
Johansson and Hansson 2016). O-linked glycans give mucins their gel forming 
properties by being able to bind water. O-glycans can interact with cells and micro-
organisms via their terminal glycans.  
Mucins can be divided into two groups: transmembrane mucins and gel-forming 
mucins(As reviewed in Johansson and Hansson 2016). Transmembrane mucins have a 
single membrane spanning domain; the C-terminus is inside the cell and can have 
intracellular signaling properties, while the N-terminus is outside the cell on the apical 
side. There are numerous transmembrane mucins. MUC3, MUC4, MUC12, MUC13 
and MUC17 are constitutively expressed. MUC3 is expressed throughout the intestine, 
but MUC12 is more specific to the colon. Transmembrane mucins cover the apical side 
of enterocytes.  
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Gel forming mucins that form the framework of mucus are secreted by goblet cells (As 
reviewed in Johansson and Hansson 2016). Goblet cells belong to the secretory lineage 
of intestinal stem cells and their maturation is partially controlled by transcription factor 
SAM pointed domain-containing Ets transcription factor (SPDEF) and Protein atonal 
homolog 1 (ATOH1), although other transcription factors are involved. MUC2 is the 
most abundant secreted mucin and it is expressed throughout the intestine; its 
production is highly stressful for goblet cells and at least two endoplasmic reticulum 
proteins are involved in its biosynthesis: Anterior gradient protein 2 homolog (AGR2) 
and endoplasmic reticulum to nucleus signaling 2 (ERN2). If constant hypersecretion of 
mucin occurs, unfolded proteins accumulate in the ER, which eventually leads to a 
decrease in secretion. The regulation of mucin biosynthesis is not completely 
understood, but it seems that translational control exists since discrepancy between 
mucin mRNA and protein levels are commonly seen. 
MUC2 is packed in secretory vesicles as multimers; low Ca2+ and high pH keep them in 
ring like structures (As reviewed in Johansson and Hansson 2016). It is thought that 
there is a basal rate of release of mucus, but upon stimulation, goblet cells can empty 
their mucin storage and secrete it into the lumen, after which goblet cells are no longer 
identifiable since they don’t contain any mucin. Because of this, it was wrongly thought 
that inflammation depleted goblet cells.  A drop in Ca2+ and rise in pH causes the 
release of mucin by expanding them into net-like sheets. In the small intestine, this is 
achieved by cystic fibrosis transmembrane conductance regulator (CFTR), which takes 
up Cl− and HCO3
− . In the colon, it’s not known how the secretion occurs. In the small 
intestine, outside the cell, meprin beta can digest the N-terminal of the mucin, which 
releases mucus from the epithelium. This makes the mucus layer porous enough for 
absorption of nutrients but at the same time it exposes the epithelium to the dangers of 
bacteria.  
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2.3.2 Impaired mucosal function in HSCR 
 
Altered epithelial mucus has been shown be involved in the progress of HAEC 
(Thiagarajah et al.  2014). Abnormal mucin disrupts the epithelial barrier and leads to 
bacterial adherence. Ednrb null mutant mice exhibit short-segment HSCR and have 
increased numbers of goblet cells (hyperplasia) accompanied with a decrease in both 
neutral and acidic mucins in the distal colon. Exactly why this happens is not known, 
but it has been shown that enteric glia and neurons play a role in epithelial health (As 
reviewed in Sharkey and Savidge 2014). 
In addition, Ednrb−/− mice have upregulated expression of transcription factors MATH1 
and SPDEF in the distal colon but not in the proximal. MUC2 mRNA levels were 
unchanged but MUC4 mRNA levels were reduced in the distal colon. Changes in 
mucins have also been observed in humans (Aslam et al. 1997a; Aslam et al. 1997b; 
Aslam et al. 1999). Notably, an increase in ratio of the intracellular mucin to the 
secreted mucin is observed, indicating problems with mucin secretion (Aslam et al. 
1998).   
A recent study found that goblet cell related factors TFF3, SPDEF, and KLF4, but not 
MUC2, are downregulated in protein and mRNA levels in human patients in both 
aganglionic and ganglionic segments (Nakamura et al. 2018). Goblet cell related factors 
downregulated in the ganglionic segment might explain why dysmotility and HAEC 
occurs even after surgical removal of the aganglionic segment. In addition, the number 
of goblet cells was found to be reduced. These results conflict with findings from the 
HSCR model Ednrb−/− mice, except for similar MUC2 levels (Thiagarajah et al. 2014). 
It is possible that when HAEC progresses, goblet cells die due to secondary effects, 
which concurrently would lead to reduced mRNA detection of goblet cell related 
factors. In contrast, MUC2 protein levels observed in HSCR stool samples were found 
to be reduced (Mattar et al. 2003). A potential reason for this discrepancy might be that 
functionally secreted MUC2 is altered (Nakamura et al. 2018). In conclusion how 
mucin regulation affects HSCR and HAEC progression is currently not well understood. 
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2.3.3 Gut immune system 
 
The intestine is constantly exposed to luminal antigens and substances included in diets 
that have modulating properties to the host microbiome (As reviewed in Mowat and 
Agace 2014). Epithelial cells express pattern recognition receptors (PRRs), such as toll-
like receptors (TLR) and NOD-like receptors (NLR), both of which can be activated by 
luminal content and lead to immune responses. The intestine has specialized 
compartments called Gut-associated lymphoid tissue (GALT) that are responsible for 
immune system in the gut. Indeed, the intestine has more immune cells than any other 
tissue and most of the immunological processes occur in the mucosa, the inner most 
layer where many different cell types are involved in the complex process of immune 
response. 
The intestine has a diverse population of T-cells (As reviewed in Belkaid et al. 2013). In 
normal conditions, the T-cell response is immunosuppressive, which is maintained 
through the production of TGF-β. TGF-β is produced mainly by antigen presenting cells 
(dendritic cells), and it favours development of the specific T-cell type T-regulatory 
(Treg) cells that suppress the gut immune system.  
The majority of the B-cells in the intestine produce IgA-antibodies (As reviewed in 
Fagarasan and Honjo 2003). IgA which is secreted in to the lumen can trap viruses and 
bacteria and prevent their translocation though the epithelium, but it can also regulate 
microbial homeostasis.  
Immune cells engage in an interplay with other cells like goblet cells in the epithelium; 
different interleukins can trigger hyperplasia or hypersecretion in goblet cells (As 
reviewed in Khan et al 2004; Oeser et al. 2015) 
An appropriately working immune system is crucial for GI health (As reviewed in 
Johansson and Hansson 2016). The cells of the immune system produce a variety of 
different cytokines like tumor necrosis factor alpha (TNFα), interferon gamma (INFγ), 
interleukin 1 beta (IL1β), interleukin 6 (IL6), interleukin 10 (IL10). Immunodeficient 
mice are more disposed to develop colitis spontaneously or have increased likelihood of 
developing it after dextran sulphate sodium (DDS) administration. Of all cytokines, 
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IL10 is the most extensively studied interleukin in relation to colitis and the 
pathogenesis of the IL10-related colitis seems to involve the mucin layer. 
 
 
2.3.4 Immune dysfunction in HSCR 
 
Changes in immune cells and different antibodies produced by B-cells have been 
observed in HSCR patients with enterocolitis (Imamura et al. 1992). Levels of IgA, IgM 
but not IgG, producing plasma cells were increased in the lamina propria. However, the 
luminal IgA content was reduced, which might predispose one to enterocolitis.  
EdnrB−/− animals with an aganglionic segment of the distal colon have reduced spleen 
size, which was characterized by a reduction in CD19+ mature B-cells, CD4+ T-cells, 
and CD8+ T-cells (Frykman et al. 2015a). The authors concluded that the effect seen is 
not caused by a lack of endothelin signaling, but rather by a lack of ENS innervation 
that causes intestinal obstruction since a bone marrow transplant from EdnrB−/− mice to 
RAG2-null mice was able to repopulate recipient bone marrow and the mice would not 
develop enterocolitis later. RAG2-null mice are immunodeficient because 
Recombination activating gene 2 (RAG2) is an essential gene for lymphocyte 
maturation as it is involved in process of V(D)J recombination. 
Abnormal immunity is also seen in the small intestine away from the aganglionic 
segment (Pierre et al. 2014). EdnrB−/−  mice at P22 have reduced expression of 
antimicrobial proteins secreted by Paneth cells, possibly compromising innate immunity 
in the small intestine. Dysfunction in intestinal immunity which occurs far away from 
the aganglionic segment might explain why the threat of HAEC still exists after 
successful surgery.  
It is well documented that the ENS communicates with the intestinal immune system 
(Ibiza et al. 2016; as reviewed in Margolis et al. 2016). Enteric fibres innervate mucosa 
which enable interaction with immune cells that express receptors for neurotransmitters. 
An abnormal ENS might be involved in the development of HAEC and it’s been shown 
that HSCR patients have immature neurons in the normoganglionic segment (Miyahara 
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et al. 2009). Another study found deficient mucosal innervation in transitional segments 
that contained ganglia (Wendelschafer-Crabb et al. 2009). 
 
 
2.3.5 Gut microbiome 
 
The GI microbiome has recently been intensively studied (As reviewed in Cani 2018). 
In fact, more than 80% of all papers published on the subject since 1977 were published 
between the years 2013 and 2017. Now, the gut microbiome has been linked to several 
different diseases from cardiometabolic disorders to psychiatric disorders. It was 
estimated that the human gut has 1014 microbes, which is ten times the number of all 
human cells (As reviewed in Backhed et al. 2005; Gill et al. 2006). A more recent study, 
however, estimated ratio to be 5:1 (Sender et al. 2016). Nevertheless, gut bacteria are 
numerous and appear to be important regulators of physiological processes in the body. 
In the colon, the loose outer layer of mucus allows bacteria with their adhesins to 
interact with mucin glycans; different mucin glycans among different species seem to 
affect what kind of bacteria resides there (Johansson et al. 2008; as reviewed in 
Johansson and Hansson 2016). It is exactly the outer layer of mucus where commensal 
bacteria reside. Some of commensal bacteria can use glycans as their sole source of 
energy, but most bacteria prefer undigested polysaccharides, meaning the host’s diet 
impacts the bacterial composition. Commensal bacteria produce important metabolites 
such as short-chain fatty acids (SCFAs). The SCFA butyrate is especially important, 
and a decrease in butyrate has been implicated in colon cancer and inflammation. It 
should be noted that, butyrate is very important for goblet cell to produce MUC2, as it 
becomes their primary source of energy when other energy sources are limited.  
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2.3.6 Abnormal microbiome in HSCR 
 
An abnormal microbiome might contribute to HAEC (Frykman et al. 2015b; as 
reviewed in Gosain 2016). Supporting this, antibiotic treatment with metronidazole 
reduces HAEC symptoms. Also, it has been shown that differences in SCFA-producing 
bacteria have been observed in HAEC patients (Demehri et al. 2016). Still, conclusive 
data about the microbial origin for HAEC does not exist. Lately, it was shown that 
Ednrb−/−  mice that develop spontaneous enterocolitis had increased numbers of 
bacteria that might play a role in HAEC (Cheng et al. 2018). Figure 3 summarizes 
different abnormalities that are thought to be involved in HAEC. Currently, the 
sequence of events leading to HAEC is unclear, as also can be derived from the lack of 
spatial and temporal etiological information in the below scheme (Figure 3). 
 
 
Figure 3. The interactions in the gut wall. The ENS regulates all aspects of intestinal 
homeostasis, and aberrant control is thought to predispose HAEC. Different functions 
that are disrupted in HSCR are shown in the figure (As reviewed in Austin, 2012). 
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3 Glial cell line–derived neurotrophic factor 
 
Neurotrophic factors (NTFs) including neurotrophins, glial cell line–derived 
neurotrophic factor (GDNF) family ligands (GFLs), and neuropoietic cytokines are a 
class of small secretory proteins or peptides that have specific receptors on the cell 
surface that activate intracellular signalling pathways (As reviewed in Boyd and Gordon 
2003). NTFs regulate virtually all aspects of the life of a neuron: they promote the 
survival, migration, and differentiation of neurons, making them particularly important 
during development but also in adulthood. NTFs can stimulate neurite outgrowth and 
axonal (re)generation and can increase synaptic plasticity. Also, their neuroprotective 
properties have been studied extensively in neurodegenerative diseases such as 
Parkinson’s disease. In animal models of Parkinson’s disease, GDNF, famous for 
promoting survival and differentiation of dopaminergic neurons, has shown promising 
results. As a RET ligand, GDNF, in conjunction with its co-receptor GDNF family 
receptor alpha-1 (GFRα1), is also an extremely important regulator of ENS 
development, regulating the survival, proliferation, and migration of enteric neuron 
precursor cells (Gianino et al. 2003; Mwizerwa et al. 2011). Consequently, knockouts of 
Gdnf, Gfra1 or Ret lack ENS innervation (Enomoto et al. 1998; Sánchez et al. 1996; 
Schuchardt et al. 1994). To date, researchers have failed to generate postnatally viable 
mouse models of HSCR that affect GDNF/GFRα1/RET signalling likely because 
GDNF/GFRα1/RET signalling is also essential for kidney development and pups with 
gene deletion or severe mutations in the encoding genes are born without kidneys and 
die soon after birth. Less impairing  mutations in genes encoding for 
GDNF/GFRα1/RET on the other hand result in normal or close to normal ENS without 
HSCR and HAEC.  
GFLs belongs to the transforming growth factor-β (TGF-β) superfamily (As reviewed in 
Airaksinen and Saarma 2002). The structure of GDNF contains seven cysteine residues 
and it has two sites of glycosylation. GDNF is a homodimer; it has a structural motif 
called a cystine knot that aids the formation of the dimer via cysteine bridges that 
stabilize the protein conformation. Indeed, all the proteins in the TGF-β superfamily 
have seven cysteine residues that are spaced in a relatively similar way. Interestingly, 
proteins in this family do not have high amino acid homology, yet they have a similar 
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conformation. GDNF is translated as preproprotein. The signal sequence (pre) is 
cleaved during secretion and finally proGDNF is enzymatically digested to yield mature 
GDNF protein. 
GDNF like all other GFLs mediate their effects primarily through the RET receptor 
tyrosine kinase, unlike other TGF-β superfamily proteins that mediate their effects 
through serine-threonine kinases(As reviewed in Airaksinen and Saarma 2002). 
However, GFLs do not bind to RET alone; rather, they bind to their preferred co-
receptor GFRα1-4 first, and then the complex is able to bind to RET. GDNF binds 
preferentially to the Gfrα1 co-receptor (Figure 4). However, there is evidence that some 
cross talk exists between other GFL co-receptors; for instance, GDNF is able to also 
bind to Gfrα2 and Gfrα3. Gfrαs can be anchored to membrane via 
glycosylphosphatidylinositol (GPI) links and they consist of 3 globular cysteine rich 
domains (except for, Gfrα4, which has only 2 domains). Domains 2 and 3 are involved 
in RET binding. RET is a single spanning transmembrane protein that has four 
extracellular cadherin-like domains of which one has a binding site for Ca2+, that is 
essential for RET activation. GDNF/GFRα1 complex interacts with RET causing the 
homodimerization and subsequent autophosphorylation of specific tyrosine residues in 
the RET kinase domain, leading to signal transduction in the cell. 
Phosphorylated tyrosines in RET can serve as docking sites for intracellular signalling 
proteins Src homology domain (Shc) and Fibroblast growth factor receptor substrate 2 
(FRS2), which then activate several signalling pathways such as the RAS/Mitogen 
activated protein kinase (RAS/MAPK), phosphatidylinositol 3-kinase/Akt (PI3K/Akt), 
and Phosphoinositide phospholipase C (PLCγ) pathway (As reviewed in Airaksinen and 
Saarma 2002). Depending on the cellular context, these pathways play an important role 
in proliferation, adhesion, migration, differentiation and survival.  
GFRα1/RET signal transduction can occur by means of cis-signalling or trans-signalling 
(As reviewed in Airaksinen and Saarma 2002). In cis-signalling, GFRα1 is anchored to 
the lipid raft and the signalling occurs in the same cell where GFRα1 is anchored as 
seen in figures 9 and 10. Alternatively GDNF can bind to freely floating GFRα1 . This 
is possible because GFRα1 is constitutively cleaved off the membrane by intracellular 
phospholipases, which release GFRα1 and enable non-cell-autonomous signalling. 
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Freely floating GDNF/ GFRα1 complexes can activate signalling pathways on RET-
expressing cells.  
 
 Figure 4. In order to signal, GDNF must first bind to its preferred co receptor GFRα1 
as shown in the figure. GFRα1 have three cysteine rich domains. The GFL-GFRα 
complex is formed usually when GFL binds domain 2, which is very important for RET 
binding as well. In addition, Ca2+ is required for RET activation. The intracellular 
domain of RET consists of four tyrosine residues that facilitate the docking of different 
adaptor proteins. GFRα1-receptor is anchored to lipid rafts on the membrane by 
glycosyl phosphatidylinositol (GPI). The other  GFLs Neurturin (NRTN), Artemin 
(ARTN) and Persephin (PRSN) bind to their cognate co receptors GFRα2, GFRα3 and 
GFRα4 respectively (not shown in figure).  (Modified from Airaksinen and Saarma 
2002). 
 
 
3.1 Enteric nervous system development and GDNF signalling 
 
Development of the ENS is very complex; starting population of 1000-2000 cells give 
rise to over a million enteric neurons and even more glial cells in adult mice small 
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intestine and colon (As reviewed in Anderson et al. 2006a). For this to happen, 
developing enteric neurons must migrate and proliferate, but some enteric neurons also 
have to differentiate at the right time while others are still proliferating and migrating. 
Moreover, many signaling pathways are required for the development of a properly 
functioning ENS especially, GDNF/GFRα1/RET and endothelin-3 (ET3) – EDNRB. 
The GDNF/GFRα1/RET signalling pathway has exceptionally great importance in ENS 
development as it controls major aspects of enteric neuron development: survival, 
proliferation, migration, and differentiation.  
The formation of the ENS is initiated when cells called neural crest cells (NCCs) 
delaminate from neural tube at E8.5 and enter the foregut one day later (As reviewed in 
Anderson et al. 2006a; Durbec et al. 1996). NCCs originate from the ectoderm layer 
formed during gastrulation, and they can give rise to several different cell lineages, such 
as enteric neurons and glia, but also melanocytes, craniofacial cartilage, bone, and 
smooth muscles (As reviewed in Bronner et al. 2012). The majority of NCCs that give 
rise to the ENS originate from levels 1-7 of somites (Figure 5) (Le Douarin and Teillet 
1973)). These NCCs are called vagal NCC-derived cells and it was shown that in the 
chick embryo, enteric ganglia were missing after ablation of vagal NCC-derived cells 
(Yntema and Hammond 1954).  
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Figure 5. Formation of the ENS. Primordial gut is colonized by vagal neural crest 
derived cells that correspond to somite levels 1-7. These cells enter the foregut at E9.5 
and migrate rostro-caudally along the gut (arrow shows the direction of the migration). 
Sacral neural crest derived cells that originate from somite level 28 colonize a small 
segment of the distal gut. Their entry into the hindgut coincides with vagal neural crest 
derived cells arrival. (Modified from Rao and Gershon 2018) 
 
 
Before entering the foregut, vagal NCC-derived cells, like all other neural crest derived 
cells, express the transcription factor SOX10 (Kuhlbrodt et al. 1998). Initial expression 
of Sox10 is necessary for the progenitors of the developing ENS as it promotes their 
survival and maintains their potency (Britsch et al. 2001; Herbarth et al. 1998; Lane and 
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Liu, 1984; Southard-Smith et al. 1998). This is highlighted by the fact that Sox10Dom 
homozygous mice have total aganglionosis of the gut because of early apoptosis of 
neural crest cells. Sox10Dom  is a naturally occurring autosomal dominant mutation with 
incomplete penetrance. The necessity of Sox10 expression in early survival of enteric 
progenitors is most likely due to its necessity for RET expression. Apoptosis in the 
subpopulation of enteric progenitors is observed in RET null mice shortly after entering 
the foregut (Taraviras et al. 1999). PHOX2B is also required for RET expression at later 
stages, but earlier RET expression is independent of PHOX2B as its expression starts 
when vagal NCC-derived cells enter the gut and start their migration (Pattyn et al. 
1999). GDNF-Ret dependent survival of vagal NCCs seem to be mediated by 
PI3K/Akt/Forkhead pathway (Srinivasan et al. 2005). FOXO1 mediated cell death is 
interrupted when PI3K phosphorylates Akt which then in turn phosphorylates FOXO1 
and FOXO3a leading to translocation of these transcription factors out of the nucleus. It 
should be noted that Neurturin, another RET ligand, also has a role in ENS development 
(Gianino et al. 2003). However, the co-receptor for Neurturin GFRα2 is not expressed 
until E14, so Neurturin doesn’t play a role in early development, but it is an important 
trophic factor regarding the survival of mature myenteric neurons and inactivating 
mutation in this gene cause hypoganglionosis of myenteric plexus. Few cases of HSCR 
have been reported where mutation is has been found in GDNF or NRTN. 
As vagal NCC-derived cells enter the foregut they are called enteric neural crest derived 
cells (ENCCs) and they start expressing markers committing them to enteric glial and 
neuronal lineages (As reviewed in Nagy and Goldstein 2017). In mice, for ENCCs to 
colonize the whole gut, which is achieved in 4 days (E9.5-E13.5), the migrating 
precursor pool must maintain a sufficient number of progenitors, but at the same time, 
timely differentiation to enteric neurons and glia must occur. Thus, balance between 
proliferation and differentiation must be tightly regulated.  
Besides being a critical factor for early survival and migration of enteric progenitors, 
GDNF/GFRα1/RET signalling stimulates proliferation of ENCCs ensuring that cell 
number is sufficient for colonization of the whole gut (Focke et al. 2001). PI3K/Akt/ 
mediates also GDNF stimulated proliferation of ENCCs. This effect is blocked by a 
selective PI3K inhibitor in primary cultures of ENCCs. In the same experiment, 
inhibition of the extracellular-signal-regulated kinase (ERK), a component of the 
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MAPK pathway had no effect on proliferation. Indeed, in the early stages of ENS 
development, GDNF acts as a proliferating signal as ENCCs are still migrating which 
happens synergistically with ET3 (Barlow et al. 2003). However, later in the 
development, GDNF stimulates migration and promotes neuronal differentiation 
whereas ET3 inhibits both migration and neuronal differentiation (Hearn et al. 1998; 
Mwizerwa et al. 2011; Wu et al. 1999; Nagy and Goldstein 2006).  
The time when a neuronal precursor exits the cell cycle is defined as the birth of that 
neuron (As reviewed in Hao and Young 2009). It’s thought that in the CNS, neuronal 
precursors exit the cell cycle before starting to express pan-neuronal markers, but in the 
ENS, like sympathetic neurons, neural crest derived cells have the capability to divide 
after expressing pan-neuronal markers such as Neuron-specific class III beta-tubulin 
(TuJ1).  
ENCCs can differentiate either into enteric neurons or glial cells (Figure 6) (Paratore et 
al. 2001; Kim et al. 2003). SOX10, an essential transcription factor in the early stages of 
ENS development, determines yet another important aspect of ENS progenitors. In 
order to generate glial cells, Sox10 expression needs to be maintained. However, enteric 
neuron differentiation requires Sox10 downregulation. Concurrently, RET expression 
needs to be maintained in the cell lineage that gives rise to enteric neurons but, in the 
glial cell lineage, RET must be downregulated. The pathway that underlies GDNF-RET 
mediated differentiation of neurons seems to be the MAPK/ERK pathway, and low 
levels of ERK activation indicated by minimal pERK prevail in undifferentiated 
neuronal precursors (Uesaka et al. 2013). 
The migration of ENCCs occurs rostro-caudally at the speed of about 40 μm/h in a 
chain-like manner where cells communicating with each other enhance the migratory 
behavior (Figure 7) (Young et al. 2004). The L1 cell adhesion molecule (L1CAM) is an 
important cell adhesion molecule for ENS migration that keeps cells in contact with 
each other and 1% of HSCR patients indeed have mutations in L1CAM (Anderson et al. 
2006b; As reviewed in Heuckeroth et al. 2018). Experimental evidence indicates that 
isolated ENCCs do not migrate as fast and their directionality is also altered, 
emphasizing the importance of chain migration. It has also been shown that if the 
starting population of ENCCs is experimentally reduced, aganglionosis of the distal gut 
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occurs (Peters-van der Sanden et al. 1993). As a lower ENCC density results in a slower 
migration speed, further colonization may be hindered because the target 
microenvironment has already become nonpermissive to further migration 
(Druckenbrod et al. 2009).  
 
 
Figure 6. From ENS progenitor to enteric neurons/glia. ENS progenitors will give rise 
to all the enteric neurons and glial cells in the gut and the decision to become a neuron 
or glial cell is depended on SOX10 and RET. The lineage that gives rise to enteric 
neurons will have to downregulate SOX10 and maintain RET expression. In contrast, 
enteric glial cells retain SOX10 but downregulate RET (Modified from Rao and 
Gershon 2018). 
  
 
Migrating cells are not a homogenous population; cells closer to the wavefront express 
Sox10, RET, PHOX2B, but cells trailing behind are more heterogenous in their 
expression pattern as they are in a different stage of maturation  (Young et al. 2004; as 
reviewed in Lake and Heuckreroth 2013). These immature neurons project neurites that 
might affect the migratory behavior of the cells at the wavefront. When migrating cells 
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behind the head of the wavefront are isolated their migratory speed is slower than the 
migratory speed of original population (Young et al. 2004). This indicates that high cell 
density and cell/cell contacts are a driving force for migration and colonization 
(“population pressure”). 
When the wavefront is approaching the cecum, circular smooth muscle layer starts to 
form, restricting ENCC migration between the circular muscle layer and serosa (As 
reviewed in Nagy and Goldstein 2017). This is exactly where myenteric ganglia 
responsible for gut motility will form. Later, a second wave of migration called radial 
migration occurs. Radial migration occurs when the myenteric plexus is formed, and the 
subset of cells migrate radially from the myenteric plexus towards the epithelium 
forming the submucosal plexus. 
 
 
Figure 7. Migratory pattern in ENS development. Migrating cells are connected to each 
other via adhesion molecules such as The L1 cell adhesion molecule (L1CAM), 
enhancing their migratory behavior. Cells in the wavefront are undifferentiated ENCCs 
while cells behind the waverfront have become immature neurons that project neurites 
along wavefront. (Modified from Lake and Heuckreroth 2013). 
 
GDNF has a major impact on the migration of enteric neural crest cells (ENCCs), and it 
is an essential driver of rostro-caudal migration of ENCCs (Natarajan et al. 2002). 
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GDNF acts as a chemoattractant for ENCCs and high levels of Gdnf mRNA are 
expressed in the mesenchyme of the foregut before the arrival of Ret expressing ENS 
precursor cells. Later, GDNF expression is seen in the cecum when migrating ENCCs 
are still in the midgut. Again, the PI3K/Akt pathway plays a key role as this pathway 
activates the expression of Rac1 at the wavefront (Guo et al. 2006). RAC1 is key 
component in lamellipodia formation and cell motility .One of the counter regulators of 
this pathway is the protein phosphatase and tensin homolog (PTEN). PTEN converts 
Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) back to Phosphatidylinositol 4,5-
bisphosphate (PIP2), thereby reducing the effects of PI3K.   
Besides being critical regulator of rostro-caudal migration, GDNF signaling is also 
required for radial migration (Uesaka et al. 2013). This was demonstrated by Uesaka et 
al. who showed an almost total absence of submucosal ganglia after conditionally 
knocking out Gfra1 at E15.5 from Gfra1GFP/+ mice that express the green fluorescent 
protein (GFP) from the Gfra1 locus. Analysis 3 days afterwards revealed that neurons 
that would normally form the submucosal plexus were mostly missing.   
Finally, a smaller portion of the ENS comes from sacral NCC-derived cells that are 
caudal to somite 28 (Burns and Douarin 1998; as reviewed in Nagy and Goldstein 
2017). In mice, Sacral NCCs colonize the hindgut, the most distal part of the gut. It has 
been estimated that these cells make up to 17% of the total enteric neurons in the 
terminal hindgut, but only 0.3% in the proximal hindgut. It is not known how much the 
sacral NCCs contribute to the ENS in humans. Sacral NCCs enter the hindgut later 
when vagal NCCs have already arrived there. Sacral NCCs are less invasive than vagal 
NCCs and this can be seen when the sacral neural tube is replaced by the vagal neural 
tube. In this setting, vagal NCCs will colonize even more proximal parts of the hindgut. 
An explanation for the difference in their migration behaviour might lie in their 
difference in RET expression (Pachnis et al. 1993). Microarray analysis revealed that 
out of 11 important ENS regulator genes, only RET expression was altered; the 
expression of RET was 4-fold higher in Vagal NCCs. Thus, it is possible that sacral 
NCCs might not respond to GDNF at all. 
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4 Conclusion 
 
The ENS is the most complex neural network of the peripheral nervous system (PNS), 
and it can independently control gut function as Bayliss and Starling showed already in 
1899 (Bayliss and Starling 1899). ENS dysfunction is thought to underlie many gut 
related pathologies, and it may be that at least in some cases dysfunction arises already 
during its development, which is a highly elaborate process that requires spatiotemporal 
coordination between signalling pathways which control migration, proliferation, and 
differentiation (As reviewed in Lake and Heuckeroth 2013). This is evident in the 
complex pathophysiology of HSCR, as dysregulation of various genes involved in ENS 
development result in disease. Yet, despite decades of active research, many of the 
HSCR susceptibility genes and mechanisms that underlie it are still not known. 
Moreover, environmental factors can influence or even disrupt the process of ENS 
development. This includes common drugs such as non-steroid anti-inflammatory drugs 
or selective serotonin inhibitors (SSRI) (As reviewed in Nijenhuis et al. 2012; Schill et 
al. 2016). 
Aganglionosis can be successfully treated by the resection of the aganglionic GI 
segment, but the risk of post-operatively acquiring the most fatal complication, HAEC, 
is still high (As reviewed in Frykman et al. 2012). This implies that in the ganglionic 
segment of HSCR patients the ENS does not function normally. Therefore, the elaborate 
interaction between the ENS and the gut requires further research.  
Currently, the exact mechanisms behind HAEC remain mostly unknown, but studies 
have shown that abnormal mucin production, immune dysfunction, and altered 
microbiome might be involved (Pierre et al. 2014; Thiagarajah et al.  2014; Cheng et al. 
2018). However, whether these factors are causes or consequences is still not known. 
Pinpointing the exact order of the sequence of events would greatly help to understand 
the progress of HAEC. 
GDNF-GFRα1-RET signalling is of special interest in studying HSCR as RET 
mutations are overwhelmingly the most common cause of HSCR accounting for circa 
50% of all familial cases (Attié et al. 1995; as reviewed in Kenny et al. 2010). The 
reason for this might not be surprising given the multifaceted effects of RET during 
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ENS development. However, kidney agenesis resulting from knocking-out of Gdnf, 
Gfra1 or Ret mice excludes the use of these mice as models of postnatal HSCR 
(Enomoto et al. 1998; Sánchez et al. 1996; Schuchardt et al. 1994).  
In summary, studying the role of GDNF/GFRα1/RET signalling in the development and 
pathophysiology GI aganglionosis is crucial to improve our understanding of HSCR and 
provide, eventually, targeted treatments to HAEC patients.  
 
  
II: EXPERIMENTAL PART 
1 INTRODUCTION 
 
The aim of the experimental part of this thesis is to shed light on the order of the 
features of early HAEC by using a GFRa1 hypomorphic mouse model (Porokuokka et 
al. 2018). Reduced GFRA1 have been reported in human infants suffering from HSCR 
(Lui et al. 2002). However, whether reduced GFRa1 expression can result in HSCR 
and/or HAEC has remained unknown.  GFRa1 hypomorphic mice were created by 
inserting an antibiotic resistance cassette within intron six of the Gfra1 gene. As a 
result, there is a 70-80% reduction in Gfra1 gene expression in the developing gut and 
kidney. Despite this reduction, the kidneys still develop normally, allowing postnatal 
analysis. Nevertheless, GFRa1 hypomorphic mice are born with long-segment HSCR. 
This is the first successful model that manipulates GDNF-GFRα1-RET signalling and 
creates a postnatally viable mouse model of HSCR and HAEC. These HSCR/HAEC 
mice are usually sacrificed between P7-P25 due to welfare issues. 
Current knowledge reported about HAEC involves various changes in the gut 
epithelium, especially in mucin-producing goblet cells (Thiagarajah et al. 2014; 
Nakamura et al. 2018; Porokuokka et al. 2018). These changes include hyperplasia of 
the goblet cells, altered mucin profile, retention of mucin, damaged and disorganized 
epithelium structure, inflammation, and bacterial adherence into the epithelium. 
However, shortage of suitable postnatal HSCR mouse models have partially hindered 
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the progress of pinpointing the exact order these events. The main focus of this thesis is 
to analyse the molecular and histological changes in HSCR/HAEC progression in 
GFRa1 hypomorphic mice. In our long segment HSCR GFRa1 hypomorphic mice, the 
distal colon is the segment that is usually aganglionic. Still, in some animals the 
proximal parts of the colon are also affected, and in few individuals, the affected 
segment extends to distal ileum. In addition, I also studied several inflammation 
markers locally in the gut and systemically in the blood.  
Goblet cells are part of the body’s first line of defence against invading pathogens, 
linking goblet cells and the immune system in a tight interplay (Johansson et al. 2008). 
For example, the regulatory region of MUC2, which is the most abundantly expressed 
mucin, has a binding site for nuclear factor kappa-light-chain-enhancer of activated B 
cells protein complex (Nf-κB) (Ahn et al. 2005). Nf-κB is a protein complex involved in 
inflammation that can be activated by cytokines such as TNFα. Interestingly, depending 
on contextual conditions, TNFα can both upregulate and downregulate MUC2 
transcription. TNFα mediated upregulation of MUC2 transcription occurs through Nf-
κB activation, but TNFα can also activate the c-Jun N-terminal kinase (JNK) pathway, 
having a negative effect on MUC2 transcription. 
Goblet cells produce different types of mucins that can be visualized histologically by 
using AB-PAS staining (Cohen et al. 2012). AB-PAS is a staining technique that 
combines two different stains: Alcian blue (AB) and Periodic Acid-Schiff base (PAS). 
AB is a basic dye that stains the acidic mucin and PAS stains the neutral mucins. Using 
these in conjunction makes visualization of the composition of mucins possible at a 
given time point. Changes in neutral and acidic mucins have been observed not only in 
inflammatory GI diseases such as Crohn’s disease and ulcerative colitis, but also in 
Hirschsprung’s disease (Rhodes et al. 1985; Thiagarajah et al. 2014; Nakamura et al. 
2018). However, the exact mechanism behind the change in mucin profile is not well 
understood.  
The gut has the most immune cells in the whole body and it is constantly exposed to 
different luminal antigens (As reviewed in Mowat and Agace 2014). This sets a high 
requirement for proper control of the immune system; immune cells need to be active 
enough to fend against bacterial invasion, but not too active to inappropriately cause 
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excess inflammation in the absence of a threat. The immune system is immensely 
complex, involving numerous different cytokines secreted by various cell types in 
communication with each other. Disruption of this communication can lead to excessive 
inflammation, and in the gut this can compromise the epithelial integrity, which might 
have critical implications on GI tract function. 
 
 
2 MATERIALS AND METHODS 
 
2.1 Animals 
 
Mice with mixed C57BL6/129ola background were used. GFRa1 hypomorphic mice 
were created by Dr. Jaan-Olle Andressoo. A positive/negative selection cassette puΔtk 
was inserted within intron six of the Gfra1 gene via homologous recombination in 
embryonic stem cells (ES) (Figure 8.). Since homozygous Gfra1hypo/hypo mice die before 
becoming fertile, two heterozygous Gfra1WT/hypo mice were bred to generate 
homozygous Gfra1hypo/hypo mice. The mice were housed in a 12h/12h light/dark cycle at 
20-22°C and had ad libitum access to standard food and water.  
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Figure 8. Gfra1 hypomorph allele. Transcription of the puΔtk cassette within intron 6 of 
the Gfra1 gene interferes with Gfra1 transcription. As a result, the hypomorphic allele is 
created. LoxP sites are indicated as triangles. 
 
 
2.2 Tissue processing 
 
Whole mount tissue samples were collected from the colon and duodenum and placed in 
freshly made 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) 
overnight. On the next day, the tissues were dehydrated and embedded using an 
ASP300 S tissue processor (Leica). 5-µm paraffin sections were cut using the Tissue-
Tek microtome (Sakura). 
 
 
2.3 Histology 
 
A combination of Alcian blue (pH 2.5) and periodic acid‒Schiff base was used to 
visualize and subsequently quantify mucins in the colon and duodenum. Standard AB-
PAS staining protocol was used. 
 
 
2.3.1 Histological quantification 
 
To quantify the ratio of acidic mucin:neutral mucin, the goblet cells in the distal third of 
the colon were counted. Only goblet cells in the lower half of the crypt were counted 
and, based on their colour, they were counted as alcian blue positive (AB+) if mostly 
light blue or deep blue, or periodic acid‒Schiff positive (PAS+) if mostly magenta or 
purple. If the cell couldn’t be put in either of the two categories, it was as AB/PAS+. 
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The same quantifying system was used in the proximal duodenum, but instead of 
counting the cells in the crypt where there are few goblet cells, goblet cells in the villi 
were counted. In addition, the total number of the goblet cells was counted. In the colon, 
goblet cells were counted in the whole length along the crypts in the distal third of the 
colon. In the proximal duodenum, goblet cells were counted in villi.  
 
 
2.4 ELISA 
 
The blood was collected by cardic puncture or the mouse was decapitated, and the blood 
was spilled on parafilm from which it was collected with pipette. The blood was then 
spun at 8000 rpm for 3min and the serum was collected; this procedure was repeated 
once.  
To perfom the analysis of serum cytokines, three Invitrogen kits were used: Invitrogen 
ProcartaPlex™ multiplex IFNg, IL12, IL4, IL5, IL6, TNFa, EPX060-20831-90, IL-1b 
Mouse ProcartaPlex™ Simplex Kit, EPX01A-26002-901, and IL-9 Mouse 
ProcartaPlex™ Simplex Kit, EPX01A-26041-901 
 
 
2.5 RNA isolation 
 
Samples from the distal colon and small intestine of E18.5-P14 mice for qPCR-analysis 
were snap-frozen immediately, and RNA from the snap-frozen tissues was isolated 
using RNAqueous Micro-kit (AM1931, Life Technologies) in accordance with the 
manufacturer’s instructions. 
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2.6 Complementary DNA (cDNA) synthesis   
 
400-500ng of RNA in 8 μl was used to synthesize cDNA. First, the samples were 
treated with DNase to eliminate genomic DNA impurities. Then, 1 μl of EDTA was 
added to prevent DNase digestion of cDNA. In the final step, 4 μl of reverse 
transcriptase (RT) buffer, 2 μl of dNTPs, 1.1 μl of dH20, 1 μl of random hexamer 
primers, 0.5 μl RT, and 0.4 μl of RNase inhibitor were added to create cDNA. For the 
negative control, all the above was added except RT. The final volume of 20 μl was 
diluted 1:10, and then either used immediately for qPCR or stored −20°C. 
 
 
2.7 Quantitive real-time PCR (qPCR) 
 
LightCycler 480 real-time PCR system (Roche Diagnostics) was used to perform the 
qPCR. For each reaction 2.5 μl of cDNA, 7.5 μl of LightCycler 480 SYBR Green I 
Master mix, and 2.5 pmol of primers were used. The samples were pipetted in 2-3 
replicates into 384-well plates sealed with an adhesive plate sealer (04729749001, 
Roche Diagnostics). The qPCR program had the following settings: pre-incubation for 
10 min at 95°C; amplification for 10 s at 95°C, 15 s at 60°C, and 15 s at 72°C for 45 
cycles; melting curve for 5 s at 95°C and 30 s at 55°C; continuous acquisition mode at 
95°C with two acquisitions per degree Celsius; and cooling for 10 s at 40°C. For 
quantification, beta-actin was used as a reference gene. LightCycler 480 Software 
Release 1.5.0 SP1, with the Absolute Quantification/2nd Derivative Max calculation 
was used to analyze the data. The primers that were used in the study are as follows:  
mActb 5’-ctaaggccaaccgtgaaaag 5’-accagaggcatacagggaca 
mAtoh1 5’-tgcgatctccgagtgagag 5’-tctcttctgcaaggtctgatttt 
mGfra1 5’-ttcccacacacgttttacca 5’-gcccgatacattggatttca 
mGlcnac6st2 5'-ggggagcagctatcacga 5'-ccctttcttcaacagcatcat 
mIfng 5’-ttcttcagcaacagcaaggc 5’-tcagcagcgactccttttcc 
 34 
 
mIlb 5’-agttgacggaccccaaaag 5’-agctggatgctctcatcagg 
mIl1a 5’-gtcggcaaagaaatcaagatg 5’-gtcttcgttttcactgtaacag 
mIl2 5’-ttgtgctccttgtcaacagc 5’-ctggggagtttcaggttcct 
mIl4 5’-aacgaggtcacaggagaagg 5’-tctgcagctccatgagaaca 
mIl5 5’-accgagctctgttgacaag 5’-tcctcgccacacttctcttt 
mIl6 5’-accacttcacaagtcggagg 5’-tgcaagtgcatcatcgttgt 
mIl10 5’-ataactgcacccacttccca 5’-cttggcaacccaagtaaccc 
mIl13 5’-gcagcatggtatggagtgtg 5’-tggcgaaacagttgctttgt 
mIl23 5’-gctgtgcctaggagtagcag 5’-tggctgttgtccttgagtcc 
mMuc2 5’-caagtgattgtgtttcaggc 5’-tggagatgttcttggtgcag 
mMuc4 5’-gagggcctcactggagagtt 5’-tctgtgttgatgttgttgctagag 
mPgp9.5 5’-tgctcctgtttcccctca 5’-cctgtcccttcagttcctca 
mSpdef 5’-gatgtactgcatgcccacct 5’-ggaggcgcagtagtgaagg 
mTgfb1 5’-tggagcaacatgtggaactc 5’-gtcagcagccggttacca 
mTnfa 5’-gatcggtccccaaagggatg 5’-tgagggtctgggccatagaa 
 
 
3 RESULTS 
 
3.1 Characterization of the Gfra1hypo/hypo GI tract 
 
Due to puΔtk cassette insertion, homozygous Gfra1hypo/hypo mice have 75-80% reduction 
in Gfra1 mRNA expression in the developing gut and kidney. Apparently, this Gfra1 
mRNA dose allows kidneys to develop normally but results in aganglionosis in the 
colon. Massive GI distention because of intestinal obstruction is observed due to 
aganglionosis (Figure 9). Gfra1hypo/hypo mice have congenital features that resembles 
childhood long-segment HSCR. 
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Figure 9. P16 Gfra1hypo/hypo vs. wild type GI tract. Aganglionosis in Gfra1hypo/hypo 
animals in the distal colon causes obstruction and does not allow passage of the stool. 
This results in gut distention up to the small intestine and thus works as a model of long 
segment Hirschsprung’s disease. At the same time, the most distal part of the GI tract is 
empty because of intestinal obstruction (A, C). The wild type GI tract is not distended 
and there are stool pellets in the colon (D). 
 
 
In the developing GI tract, Gfra1 is expressed both by migrating enteric neural crest 
cells and in the mesenchyme (Durbec et al. 1996), whereas during the first postnatal 
week, Gfra1 expression is sustained only in ENCC derived cells. Because of reduced 
Gfra1 expression, neural crest cells are unable to colonize the distal colon, and at 
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postnatal (P) day 10, no Gfra1 mRNA can be observed (Figure 10A). As expected from 
complete aganglionosis, levels of PGP9.5, a pan-neuronal marker, are also reduced to 
almost zero in the distal colon of Gfra1hypo/hypo, (Figure 10B).    
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Figure 10. Distal colon lacks enteric ganglia in Gfra1hypo/hypo mice. At P10 Gfra1WT/hypo 
have reduced Gfra1 expression (A), but this has minimal effect on the ENS innervation 
as expression of pan-neuronal marker PGP9.5 is comparable to wild types (B). In 
contrast, Gfra1hypo/hypo have very low levels of PGP9.5 due to aganglionosis (B). Data is 
presented as mean ± SEM. P<0.05= *, P<0.01**, P<0.001=***. A n=5-7, B n=4-14. 
Statistical analyses were performed with one-way-ANOVA and Tukey’s multiple 
comparison tests.  
 
 
3.2 Goblet cells are altered in the colon of Gfra1hypo/hypo mice 
 
Goblet cells are involved in intestinal homeostasis. In order to better understand the 
order of the events leading to the final stages of HAEC including sepsis, I counted 
goblet cells in distal colon crypts at P2, P5, and P10 and quantified the mucin profile.  
Goblet cell hyperplasia was observed at P10 in the GI tract of Gfra1hypo/hypo mice, but 
not earlier (Figure 11). On the other hand, Gfra1WT/hypo have same amount of goblet 
cells at every time point as wild type controls.  
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Figure 11. Number of goblet cells in the distal colon. At P2- and P5 no difference is 
observed (A, B). At P10, Gfra1hypo/hypo mice have over a 30% increase in number of 
goblet cells compared to wild types and heterozygotes. (C). Data is presented as mean ± 
SEM. P<0.05= *, P<0.01**, P<0.001=***. A n=3-8, B n=4-5, C n=3-5. Statistical 
analyses were performed with one-way-ANOVA and Tukey’s multiple comparison tests 
 
 
Next, I quantified the mucin profile inside goblet cells with AB/PAS staining. While 
only a nonsignificant trend towards a reduction of acidic mucins was observed at P2 in 
Gfra1hypo/hypo distal colon, this reduction was significant at P5 and this effect persisted 
also to P10 (Figure 12). Interestingly, Gfra1WT/hypo mice, which have an apparently 
normal ENS throughout the gut, also had a significant reduction in acidic mucin, 
however only at P10 (Figure 12C). This suggests that mucin synthesis may be 
controlled independent of the presence or absence of the ENS as a function of GFRa1 
levels, thus warranting further investigation. As shown in Figure 13, a different mucin 
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profile in Gfra1hypo/hypo colons is clearly visible relative to controls already at P5, 
showing that shift in mucin profile synthesis occurs before goblet cell hyperplasia.  
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Figure 12. Goblet cell mucin profile in the distal colon. No significant change in mucin 
profile is observed at P2, aside from a nonsignificant trend towards reduction in 
Gfra1hypo/hypo distal colon (A). A significant reduction in acidic mucin is seen from P5 
onwards in Gfra1hypo/hypo distal colon (B, C). Interestingly, at P10, Gfra1WT/hypo have less 
acidic mucin in the goblet cells compared to wild types (C). Data is presented as mean ± 
SEM. P<0.05= *, P<0.01**, P<0.001=***. A n=3-4, B n=4-5, C n=4-6. Statistical 
analyses were performed with one-way-ANOVA and Tukey’s multiple comparison 
tests. 
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Figure 13. Gfra1hypo/hypo colon crypt vs wild type crypt at P5. At the bottom of the wild 
type crypt goblet cells produce more light-blue stained acidic mucin (black arrow, left 
panel). Mucins at the bottom of the Gfra1hypo/hypo crypt stain magenta/purple indicating a 
shift away from acidic mucin (black arrow, right panel). Samples were stained with AB-
PAS staining. Scale is indicated in each image. 
 
 
3.3 Goblet cell related gene expression in the distal colon 
 
Several studies have shown that MUC transcripts or protein levels are altered in HSCR 
patients (Aslam et al. 1997a; Aslam et al. 1997b; Aslam et al. 1999; Thiagarajah et al.  
2014; Nakamura et al. 2018). Thus, Muc2 and Muc4 mRNA levels were studied at five 
different timepoints (E18.5, P2, P5, P10 and P12-P15). 
MUC2, the most abundant mucin in the gut, was upregulated in the distal colon of 
Gfra1hypo/hypo animals between P5 and P10, after which it returned to control levels at 
P12-P15 (Figure 14a). 
Muc4 had similar expression levels as Muc2, but a statistical difference was only seen at 
P10 (Figure 14b). 
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Figure 14. Muc2 (A) and Muc4 (B) expression in the distal colon between E18.5-P12-
P15. Two-fold increase was observed in Muc2 expression of Gfra1hypo/hypo animals at P5 
and P10 (A). An increase in Muc4 expression in Gfra1hypo/hypo animals was observed 
only at P10 (B). Data is presented as mean ± SEM. P<0.05= *, P<0.01**, 
P<0.001=***. Separate statistical analyses were performed at each timepoint (E18.5, 
P2, P5, P10, P12-P15) with one-way-ANOVA and Tukey’s multiple comparison tests 
 
Goblet cells differentiate from stem cells at the bottom of the crypt. For this to occur, 
transcription factors ATOH1 and SPDEF are required (Lo et al. 2017). At P10, there 
was a trend towards upregulation in Gfra1hypo/hypo animals in both of these genes, but it 
did not reach statistical significance (Figure 15).  
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Figure 15. Expression of Spdef (A) and Atoh1 (B) in the distal colon at P10. No 
statisical difference between groups. Data is presented as mean ± SEM. A n=5-7, B 
n=5-7. Statistical analyses were performed with one-way-ANOVA and Tukey’s 
multiple comparison tests. 
  
Mucins produced by goblet cells undergo extensive post-translational modifications, 
whereupon sugars and modified sugars are added to the protein backbone (As reviewed 
in Bergström and Xia 2013). N-acetylglucosamine 6-O-sulfotransferase-2 
(GlcNAc6ST-2) has been shown to be crucial for the transfer of sulphate groups in the 
mucin protein backbone (Tobisawa et al. 2010). Gfra1hypo/hypo animals show a significant 
increase in Glcnac6st-2 mRNA as compared to both wild types and heterozygous 
animals (Figure 16). 
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Figure 16. Expresion of Glcna6st-2 in the distal colon at P10. Three-fold increase in 
Glcnac6st-2 was observed in Gfra1hypo/hypo (A). Data is presented as mean ± SEM. 
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P<0.05= *, P<0.01**, P<0.001=***. A n=8-10, B n=7-9. Statistical analyses were 
performed with one-way-ANOVA and Tukey’s multiple comparison tests. 
 
 
3.4 Inflammation genes 
 
Inflammation in the gut has been reported in HSCR patients (Frykman et al 2015b; 
Demehri et al. 2016). To test for inflammation in our animals, the following cytokines 
were tested with qPCR: Ifng, Il1b, Il1a, Il2, Il4, Il5, Il6, Il10, Il13, Il23, Tnfa, Tgfb1. 
Out of all tested cytokines, TNFa mRNA was the only one that was significantly 
upregulated, and only at timepoint P10 in Gfra1hypo/hypo mice. There was already a trend 
at P2 onwards, but potentially due to a relatively low n there, was no statistical 
significance (Figure 17). Il1b had a similar expression pattern across genotypes to Tnfa, 
but due to high variation, there was also no significant difference (Figure 17b). For 
Tgfb1 expression, no diffrence was seen at any point.   
Il5, Il10 and Il23 were analyzed at P10 but no statisical difference was seen. Still,  there 
was trend towards upregulation of Il1a (Figure 18). 
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Figure 17. Tnfa (A), Il1b (B), Tgfb1 (C) expression in the distal colon between E18.5-
P12-P15. Only Tnfa was significantly increased at P10 in Gfra1hypo/hypo animals (A). 
Data is presented as mean ± SEM. P<0.05= *, P<0.01**, P<0.001=***. Statistical 
analyses were performed at every timepoint (E18.5, P2, P5, P10, P12-P15) with one-
way-ANOVA and Tukey’s multiple comparison tests. 
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Figure 18. Il5 (A), Il23 (B) and Il1a (C) expression  in the distal colon at P10. No 
statisical difference between groups. Data is presented as mean ± SEM. A n=3-5, B 
n=5-7, C=4-7. Statistical analyses were performed with one-way-ANOVA and Tukey’s 
multiple comparison tests. 
 
 
Serum cytokine levels were also measured using ELISA. The following cytokines were 
tested: IFNg, IL1b, IL4, IL5, IL6, IL9, IL12, TNFa. Out of 8 tested cytokines, 3 gave 
signal: IL5, IL6 and TNFa. No differences were observed, although at P14-P16 group 
one Gfra1hypo/hypo mouse had elevated levels of TNFa and IL6 (Figure 19). 
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Figure 19. TNFa (A,D), IL6 (B,E) and IL5 (C,F) levels in the serum at P10-P14-P16. 
No differences were observed. At P14-P16 one Gfra1hypo/hypo had elevated level of TNFa 
and IL6 (D,E). Data is presented as mean ± SEM. Statistical analyses were performed 
with one-way-ANOVA and Tukey’s multiple comparison tests. 
 
 
3.5 Small intestine 
 
The duodenum was also analyzed to see if changes in the goblet cells in the colon are 
due to reduced GDNF signalling or lack of the ENS. Histological images of the 
duodenum are shown in Figure 20.  
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Goblet cells were counted and analysed for mucin at P10 in the proximal duodenum. No 
difference in either parameter was seen (Figure 21a). Goblet cells in the villi were 
mainly PAS-positive (Figure 21b). Since the duodenum of Gfra1hypo/hypo mice is 
normally innervated and no changes in goblet cells were observed, changes in the colon 
can be attributed to a lack of innervation, rather than a lack of GDNF signalling. 
Finally, cytokine mRNA levels were analyzed from the small intestine to see if the 
inflammation that was seen in the colon was also seen in duodenum (Figure 22). 
However, no changes in the expression of cytokines were observed. 
 
  
Figure 20. Wild type (left) vs Gfra1hypo/hypo (right) proximal duodenum at P10. Goblet 
cells in both duodena express mainly neutral mucins as visualized with AB-PAS 
staining. 
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Figure 21. Goblet cells in the proximal duodenum at P10. No difference in the number 
of goblet cells or in their mucin composition was observed. Data is presented as mean ± 
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SEM. A n=4, B n=4. Statistical analyses were performed with one-way-ANOVA and 
Tukey’s multiple comparison tests. 
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Figure 22. Tnfa (A) and Il1b (B) expression in the small intestine at  P7.5 and P10. Data 
is presented as mean ± SEM. Statistical analyses were performed at each timepoint 
(P7.5, P10) with one-way-ANOVA and Tukey’s multiple comparison tests. 
  
 
4 DISCUSSION 
 
The aim of this study was to provide insight into the order of events which contribute to 
HAEC. I investigated goblet cell mucin profile changes, goblet cell hyperplasia, 
epithelial histology, and analysed molecular parameters of goblet cell function as well 
as inflammation with QPCR in the gut and with ELISA in the serum. For this, GFRa1 
hypomorphic mice were examined at various time points beginning from E18.5. No 
changes were observed in mRNA expression of mucins (Muc2, Muc4) or inflammatory 
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genes (Il1b, Tgfb1, Tnfa) at E18.5. At P2, goblet cell number in the crypts of the distal 
third of the colon was similar between groups, and there was no statistical difference in 
mucin profile, even though there seems to be a trend towards downregulation of AB+ 
mucin in hypomorphs, signalling a shift away from a more acidic mucin profile. QPCR-
analysis at P2 revealed a trend in upregulation of early phase inflammatory genes IL1b 
and Tnfa, but perhaps due to a low number of animals, it did not reach statistical 
significance. P5 was first time point where statistically significant changes could be 
seen in Gfra1hypo/hypo animals. A trend towards upregulation of Tnfa was observed at this 
time point. Interestingly, Muc2, the main secreted mucin was upregulated at this point. 
This is in opposition to other studies, where either no change or downregulation of 
Muc2 has been observed (Thiagarajah et al. 2014; Nakamura et al. 2018) A potential 
reason for this discrepancy might be that the MUC2 mRNA was measured at later time 
points in previous studies when there are already secondary changes. Histological 
analyses showed mucin retention in the colon, which might reflect mucin 
overproduction indicated by upregulated MUC2. However, MUC2 mRNA and protein 
levels do not always correlate, so a conclusive analysis would require measurement of 
protein levels of MUC2. 
 In addition, goblet cells in the distal colon at time point P5 had started to produce 
abnormal mucin in Gfra1hypo/hypo animals, observed at the bottom of the crypt. Normally, 
goblet cells at the bottom of the crypts of the distal colon produce acidic mucin, shown 
by AB+ staining. In Gfra1hypo/hypo mice, there was a shift towards neutral mucin 
production, shown by an increase in PAS+ staining. It is not known why this shift in 
mucin profile occurs. However, studies have implied that acidic mucin has protective 
properties and may prevent bacterial adherence into the epithelium (Tobisawa et al. 
2012). Sulfation of mucins is one of the main ways to make mucins acidic. In this 
process, an acidic sulphate group is added to the sugar chain of mucin proteins.  
Interestingly at P10, the Gfra1WT/hypo mice also had less acidic mucin. These mice have a 
normal lifespan and are fertile, with seemingly no gut related issues. Further study is 
required to see if these mice are more susceptible to DSS, since they have less 
protective acidic mucin.  
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In a study done by Tobisawa et al., it was shown that mice that were deficient in N-
acetylglucosamine 6-O-sulfotransferase-2 (GlcNAc6ST-2), present an absence of acidic 
mucin (AB+). These mice were more susceptible to dextran sodium sulphate (DSS) 
induced colitis. For this reason, Glcnac6st-2 mRNA expression was analysed at P5 
where a shift away from acidic mucin is seen for the first time in Gfra1hypo/hypo mice, and 
at P10 where the same effect persisted. No change at P5 was observed (data not shown), 
but at P10, Glcnac6st-2 was significantly upregulated. If Glcnac6st-2 correlates with 
acidic mucin production, the observation that Glcnac6st-2 mRNA is upregulated while 
the amount of acidic mucin is diminished requires further study. It is possible that 
mRNA levels do not reflect the protein levels. Also, the interpretation of Glcnac6st-2 
mRNA is complicated by the fact that Glcnac6st-2 is also expressed in high endothelial 
venules (HEVs) (Bistrup et al. 1999). Thus, immunohistological analysis is required to 
address if protein derived from the Glcnac6st-2 allele is changed, and if so, in which 
cells. As one option, upregulation of Glcnac6st-2 expression may reflect an attempt to 
compensate for the decline of acidic mucin production around P5 and P10. 
At P10, goblet cell hyperplasia is detected in Gfra1hypo/hypo mice. qPCR-analysis did not 
show a significant upregulation of Atoh1 and Spdef, transcription factors involved in 
goblet cell differentiation. This is seemingly in opposition to the upregulation observed 
in Ednrb null mice (Thiagarajah et al. 2014). That said, we did observe around 30% 
goblet cell hyperplasia in our Gfra1hypo/hypo animals, and there was a trend in Atoh1 and 
Spdef upregulation (around 1.5 fold). It is possible that statistical significance would 
have been reached if the number of mice analyzed had been higher.  
ELISA results indicated that systemic inflammation did not occur P10-P14-P16 
although one Gfra1hypo/hypo animal had high levels of IL6 and TNFa at P14-16. This 
indicates that inflammation is neither an early nor mid-stage event in HAEC. Moreover, 
inflammation markers were not upregulated in the small intestine, indicating that at the 
mRNA level only the aganglionic colon segment is affected.  
One of the key findings of this study is that changes in goblet cells seem to be due to a 
lack of the ENS rather than reduced GDNF signalling directly, as no changes were 
observed in the small intestine. There the ENS has developed normally, yet there is 
reduction Gfra1 expression. This indicates that the changes observed in the colon are 
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likely due to the lack of ENS innervation, rather than a direct effect from GDNF-
GFRa1-RET signalling itself. 
 
 
5 CONCLUSION 
 
The GFRa1 hypomorphic mouse line is the first postnatally viable HSCR model that 
affects GDNF-GFRα1-RET signalling. We have observed a shift away from acidic 
mucin production, followed by goblet cell hyperplasia, and an increase in certain 
cytokine production in our Gfra1hypo/hypo mice. There was already a trend in the 
production of certain cytokines at P2, with no significance achieved until P10, while a 
shift in mucin profile, missing at P2, already appeared at P5. Nevertheless, it is likely 
that these events happen relatively concurrently, likely between P2-P5. Analysis at P3-
P4 would be required to see if these events indeed coincide or if one precedes the other. 
Still, what drives goblet cells to begin producing less acidic mucin is not known but 
constitutes an important future research question. It is entirely possible that the lack of 
an ENS causes disruption in the epithelial-immune-ENS axis, which alters the goblet 
cell function. In conclusion, we have found that GFRa1 hypomorphic animals develop a 
HSCR-like phenotype where altered mucin production by goblet cells is the first 
histopathological hallmark preceding HAEC. Possibly, pharmacological prevention of 
this mucin shift may reduce or abolish HAEC, but whether this is the case requires 
further studies. Key histopathological findings summarizing this work as well as the 
work by other group members are shown in Figure 23. 
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Figure 23. Graphical illustration of key histopathlogical findings in Gfra1hypo/hypo mice. 
 
 
6 ACKNOWLEDGMENTS 
 
I would like to thank Daniel Garton for editing the thesis text, Jaan-Olle Andressoo for 
scientific mentoring and supervising the master thesis project, Lauriina Porokuokka for 
general support, and Sonja Huovila for designing the art work in Figure 29. 
 
 
7 REFERENCE 
 
Ahn DH, Crawley SC, Hokari R, Kato S, Yang SC, Li JD, Kim YS: TNF-alpha 
activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cell 
Physiol Biochem., 15(1-4): 29-40, 2005 
Airaksinen MS and Saarma M: The GDNF family: Signalling, biological functions and 
therapeutic value. Nat Rev Neurosci, 3(5): 383-394, 2002 
 52 
 
Anderson RB, Newgreen DF, Young HM: Neural crest and the development of the 
enteric nervous system. Adv Exp Med Biol, 589: 81-196, 2006a 
Anderson RB, Turner KN, Nikonenko AG, Hemperly J, Schachner M, Young HM: The 
cell adhesion molecule l1 is required for chain migration of neural crest cells in the 
developing mouse gut. Gastroenterology, 130(4): 1221-1232, 2006b 
Aslam A, Spicer RD, Corfield AP: Biochemical analysis of colonic mucin glycoproteins 
in children with Hirschsprung disease show disease specific alterations. Biochem Soc 
Trans, 25(1): 8S, 1997a  
Aslam A, Spicer RD, Corfield AP: Children with Hirschsprung’s disease have an 
abnormal colonic mucus defensive barrier independent of the bowel innervation status. 
J Pediatr Surg, 32(8): 1206-1210, 1997b 
Aslam A, Spicer RD, Corfield AP: Turnover of radioactive mucin precursors in the 
colon of patients with hirschsprung's disease correlates with the development of 
enterocolitis. J Pediatr Surg, 33(1): 103-105, 1998 
Aslam A, Spicer RD, Corfield AP: Histochemical and genetic analysis of colonic mucin 
glycoproteins in Hirschsprung’s disease. J Pediatr Surg, 34(2): 330-333, 1999 
Attié T1, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, 
Nihoul-Fékété C, Munnich A, Ponder BAJ and Lyonnet: Diversity of RET proto-
oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet, 
4(8): 1381-6, 1995 
Austin KM: The pathogenesis of hirschsprung's disease-associated enterocolitis. Semin 
Pediatr Surg, 21(4): 319-327, 2012 
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-bacterial mutualism 
in the human intestine. Science (New York, N.Y.), 307(5717): 1915-1920, 2005 
Barlow A, de Graaff E, Pachnis V: Enteric nervous system progenitors are coordinately 
controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase 
RET. Neuron, 40(5): 905-916, 2003 
Bayliss WM and Starling EH: The movements and innervation of the small intestine. J 
Physiol, 24(2): 99–143, 1899 
Belkaid Y, Bouladoux N, Hand TW: Effector and memory T cell responses to 
commensal bacteria. Trends in Immunol, 34(6), 299-306, 2013 
Bergstrom KS and Xia L: Mucin-type O-glycans and their roles in intestinal 
homeostasis. Glycobiology, 23(9): 1026-1037, 2013 
Bistrup A, Bhakta S, Lee JK, Belov YY, Gunn MD, Zuo FR, . . . Hemmerich S: 
Sulfotransferases of two specificities function in the reconstitution of high endothelial 
cell ligands for L-selectin. J Cell Biol, 145(4): 899-910, 1999 
 53 
 
Boyd JG and Gordon T: Neurotrophic factors and their receptors in axonal regeneration 
and functional recovery after peripheral nerve injury. Mol Neurobiol, 27(3):277-324, 
2003 
Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier 
C, Wegner M: The transcription factor Sox10 is a key regulator of peripheral glial 
development. Genes Dev. 15(1): 66–78, 2001   
Bronner ME: Formation and migration of neural crest cells in the vertebrate embryo. 
Histochem Cell Biol, 138(2): 179-186, 2012 
Burns AJ and Douarin NM: The sacral neural crest contributes neurons and glia to the 
post-umbilical gut: spatiotemporal analysis of the development of the enteric nervous 
system. Development, 125(21): 4335-47, 1998 
Cani PD: Human gut microbiome: Hopes, threats and promises. Gut, 67(9): 1716-1725, 
2018 
Cheng Z, Zhao L, Dhall D, Ruegger PM, Borneman J, Frykman PK: Bacterial 
microbiome dynamics in post pull-through hirschsprung-associated enterocolitis 
(HAEC): An experimental study employing the endothelin receptor B-null mouse 
model. Front Surg, 5:30; 2018 
Cohen M, Varki NM, Jankowski MD, Gagneux P: Using Unfixed, Frozen Tissues to 
Study Natural Mucin Distribution. J Vis Exp, (67): 3928, 2002 
Demehri FR, Frykman PK, Cheng Z, Ruan C, Wester T, Nordenskjöld A, Kawaguchi 
A, Hui TT, Granström AL, Funari V, Teitelbaum DH: Altered fecal short chain fatty 
acid composition in children with a history of Hirschsprung-associated enterocolitis. J 
Pediatr Surg. 51(1): 81–86, 2016   
Druckenbrod NR and Epstein ML: Age-dependent changes in the gut environment 
restrict the invasion of the hindgut by enteric neural progenitors. Development, 136(18): 
3195-3203, 2009 
Durbec PL, Larsson-Blomberg LB, Schuchardt A, Costantini F, Pachnis V: Common 
origin and developmental dependence on c-ret of subsets of enteric and sympathetic 
neuroblasts. Development, 122(1): 349-358, 1996 
Emison ES, McCallion AS, Kashuk, CS, Bush RT, Grice E, Lin S, Chakravarti A: A 
common sex-dependent mutation in a RET enhancer underlies hirschsprung disease 
risk. Nature, 434(7035): 857-863, 2005 
Enomoto H, Araki T, Jackman A, Heuckeroth RO, Snider WD, Johnson EM Jr, 
Milbrandt J: GFR alpha1-deficient mice have deficits in the enteric nervous system and 
kidneys. Neuron, 21(2): 317-324, 1998 
Fagarasan S and Honjo T: Intestinal IgA synthesis: Regulation of front-line body 
defences. Nat Rev.Immunol, 3(1): 63-72, 2003 
 54 
 
Focke PJ, Schiltz CA, Jones SE, Watters JJ, Epstein ML: Enteric neuroblasts require the 
phosphatidylinositol 3-kinase pathway for GDNF-stimulated proliferation. J Neurobiol, 
47(4): 306-317, 2001 
Frykman PK, Cheng Z, Wang X, Dhall D: Enterocolitis causes profound lymphoid 
depletion in endothelin receptor B- and endothelin 3-null mouse models of 
hirschsprung-associated enterocolitis. Eur J Immunol, 45(3): 807-817, 2015a 
Frykman PK, Nordenskjöld A, Kawaguchi A, Hui TT, Granström AL, Cheng Z, Tang J, 
Underhill DM, Iliev I, Funari VA, Wester T; HAEC Collaborative Research Group 
(HCRG): Characterization of Bacterial and Fungal Microbiome in Children with 
Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study. 
PLoS One, 24;10(4), 2015b 
Frykman PK and Short SS: Hirschsprung-associated enterocolitis: Prevention and 
therapy. Semin Pediatr Surg, 21(4): 328-335, 2012 
Furness JB, Callaghan BP, Rivera LR, Cho HJ: The enteric nervous system and 
gastrointestinal innervation: Integrated local and central control. Adv Exp Med Biol, 
817: 39-71, 2014 
Gershon MD and Tack J: The serotonin signaling system: From basic understanding to 
drug development for functional GI disorders. Gastroenterology, 132(1): 397-414, 2007 
Gianino S, Grider JR, Cresswell J, Enomoto H, Heuckeroth RO: GDNF availability 
determines enteric neuron number by controlling precursor proliferation. Development, 
130(10): 2187-2198, 2003 
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, . . . Nelson KE: 
Metagenomic analysis of the human distal gut microbiome. Science, 312(5778): 1355-
1359, 2006 
Gosain A: Established and emerging concepts in Hirschsprung's-associated 
enterocolitis. Pediatr Surg Int, 32(4): 313-20, 2016 
 
Guo F, Debidda M, Yang L, Williams DA, Zheng Y: Genetic deletion of Rac1 GTPase 
reveals its critical role in actin stress fiber formation and focal adhesion complex 
assembly. J Biol Chem , 281(27): 18652-18659, 2006 
Hansen MB: Neurohumoral control of gastrointestinal motility. Physiol Res , 52(1): 1-
30, 2003 
Hao MM and Young HM: Development of enteric neuron diversity. J Cell Mol Med, 
13(7): 1193-1210, 2009 
Hearn CJ, Murphy M, Newgreen D: GDNF and ET-3 differentially modulate the 
numbers of avian enteric neural crest cells and enteric neurons in vitro. Dev Biol, 
197(1): 93-105, 1998 
 55 
 
Herbarth B, Pingault V, Bondurand N, Kuhlbrodt K, Hermans-Borgmeyer I, Puliti A, . . 
. Wegner M: Mutation of the sry-related Sox10 gene in dominant megacolon, a mouse 
model for human hirschsprung disease. Proc Natl Acad Sci U S A , 95(9): 5161-5165, 
1998 
Heuckeroth RO: Hirschsprung disease - integrating basic science and clinical medicine 
to improve outcomes. Nat Rev Gastroenterol Hepatol , 15(3): 152-167, 2018 
Ibiza S, Garcia-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, . . . Veiga-
Fernandes H: Glial-cell-derived neuroregulators control type 3 innate lymphoid cells 
and gut defence. Nature, 535(7612): 440-443, 2016 
Imamura A, Puri P, O'Briain DS, Reen DJ: Mucosal immune defence mechanisms in 
enterocolitis complicating hirschsprung's disease. Gut, 33(6): 801-806, 1992  
Johansson ME and Hansson GC: Immunological aspects of intestinal mucus and 
mucins. Nat Rev.Immunol, 16(10): 639-649, 2016 
Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L and Hansson GC: The 
inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. 
Proc Natl Acad Sci U S A, 105(39): 15064-9, 2008  
Kenny SE, Tam PK, Garcia-Barcelo M: Hirschsprung's disease. Semin Pediatr Surg, 
19(3): 194-200, 2010 
Khan WI and Collins SM: Immune-mediated alteration in gut physiology and its role in 
host defence in nematode infection. Parasite Immunol, 26(8-9): 319-26, 2004 
Kiela PR and Ghishan FK: Physiology of intestinal absorption and secretion. Best Pract 
Res Clin Gastroenterol. , 30(2): 145-159, 2016 
Kim J, Lo L, Dormand E and Anderson DJ: SOX10 maintains multipotency and inhibits 
neuronal differentiation of neural crest stem cells. Neuron, 38: 17–31, 20032018 
Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M: Sox10, a novel 
transcriptional modulator in glial cells. J Neurosci, 18(1): 237-250, 1998  
Lake JI and Heuckeroth RO: Enteric nervous system development: Migration, 
differentiation, and disease. Am J Physiol Gastrointest Liver Physiol , 305(1): G1-24, 
2013 
Lane PW and Liu HM: Association of megacolon with a new dominant spotting gene 
(dom) in the mouse. J Hered, 75(6): 435-439, 1984 
Le Douarin NM and Teillet MA: The migration of neural crest cells to the wall of the 
digestive tract in avian embryo. J Embryol Exp Morphol., 30(1): 31-48, 1973 
Lo YH, Chung E, Li Z, Wan YW, Mahe MM, Chen MS, . . . Shroyer NF: 
Transcriptional regulation by ATOH1 and its target SPDEF in the intestine. Cell Mol 
Gastroenterol Hepatol , 3(1): 51-71, 2016 
 56 
 
Lui VC, Samy ET, Sham MH, Mulligan LM and Tam PK: Glial cell line-derived 
neurotrophic factor family receptors are abnormally expressed in aganglionic bowel of a 
subpopulation of patients with Hirschsprung's disease. Lab Invest, 82(6): 703-12, 2002 
Margolis KG, Gershon MD, Bogunovic M: Cellular organization of neuroimmune 
interactions in the gastrointestinal tract. Trends in Immunol, 37(7): 487-501, 2016 
Marty TL, Seo T, Matlak ME, Sullivan JJ, Black RE, Johnson DG: Gastrointestinal 
function after surgical correction of Hirschsprung's disease: long-term follow-up in 135 
patients. J Pediatr Surg, 30(5): 655-8, 1995 
Mattar AF, Coran AG, Teitelbaum DH: MUC-2 mucin production in hirschsprung's 
disease: Possible association with enterocolitis development. J Pediatr Surg , 38(3): 
417-21; discussion 417-21, 2003 
McConalogue K and Furness JB: Gastrointestinal neurotransmitters. Baillieres Clin 
Endocrinol Metab , 8(1): 51-76, 1994  
Miyahara K, Kato Y, Seki T, Arakawa A, Lane GJ, Yamataka A: Neuronal immaturity 
in normoganglionic colon from cases of hirschsprung disease, anorectal malformation, 
and idiopathic constipation. J Pediatr Surg , 44(12): 2364-2368, 2009  
Mowat AM and Agace WW: Regional specialization within the intestinal immune 
system. Nat Rev.Immunol, 14(10): 667-685, 2014 
Murphy F and Puri P: New insights into the pathogenesis of hirschsprung's associated 
enterocolitis. Pediatr Surg Int , 21(10): 773-779, 2005 
Mwizerwa O, Das P, Nagy N, Akbareian SE, Mably JD, Goldstein AM: Gdnf is 
mitogenic, neurotrophic, and chemoattractive to enteric neural crest cells in the 
embryonic colon. Dev Dyn, 240(6): 1402-1411, 2011 
Nagy N and Goldstein AM: Endothelin-3 regulates neural crest cell proliferation and 
differentiation in the hindgut enteric nervous system. Dev Biol, 293(1): 203-217, 2006 
Nagy N and Goldstein AM: Enteric nervous system development: A crest cell's journey 
from neural tube to colon. Semin Cell Dev Biol , 66: 94-106, 2017 
Nakamura H, Tomuschat C, Coyle D, O'Donnel AM, Lim T, Puri P: Altered goblet cell 
function in hirschsprung's disease. Pediatr Surg Int, 34(2): 121-128, 2018 
Natarajan D, Marcos-Gutierrez C, Pachnis V, de Graaff E: Requirement of signalling by 
receptor tyrosine kinase RET for the directed migration of enteric nervous system 
progenitor cells during mammalian embryogenesis. Development, 129(22): 5151-5160, 
2002  
Nijenhuis CM, Horst PG, Berg LT, Wilffert B: Disturbed development of the enteric 
nervous system after in utero exposure of selective serotonin re-uptake inhibitors and 
tricyclic antidepressants. part 1: Literature review. Br J Clin Pharmacol , 73(1): 16-26, 
2012 
 57 
 
Oeser K, Schwartz C, Voehringer D: Conditional IL-4/IL-13-deficient mice reveal a 
critical role of innate immune cells for protective immunity against gastrointestinal 
helminths. Mucosal Immunol, 8(3):672-82, 2015 
Pachnis V, Mankoo B, Costantini: Expression of the c-ret proto-oncogene during mouse 
embryogenesis. Development, 119(4): 1005-1017, 1993 
Paratore C, Goerich DE, Suter U, Wegner M and Sommer L: Survival and glial fate 
acquisition of neural crest cells are regulated by an interplay between the transcription 
factor Sox10 and extrinsic combinatorial signaling. Development, 128: 3949–3961, 
2001 
Parisi MA: Hirschsprung disease overview. In M. P. Adam, H. H. Ardinger, R. A. 
Pagon, S. E. Wallace, L. J. H. Bean, K. Stephens & A. Amemiya (Eds.), 
GeneReviews((R)), 1993  
Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF: The homeobox gene Phox2b is 
essential for the development of autonomic neural crest derivatives. Nature, 399(6734): 
366-370, 1999 
Peters-van der Sanden MJ, Kirby ML, Gittenberger-de Groot A, Tibboel D, Mulder MP 
and Meijers C: Ablation of various regions within the avian vagal neural crest has 
differential effects on ganglion formation in the fore-, mid- and hindgut. Dev Dyn, 
196(3): 183-94, 1993 
Pierre JF, Barlow-Anacker AJ, Erickson CS, Heneghan AF, Leverson GE, Dowd SE, 
Gosain A: Intestinal dysbiosis and bacterial enteroinvasion in a murine model of 
hirschsprung's disease. J Pediatr Surg, 49(8): 1242-1251, 2014 
Pini Prato A, Rossi V, Avanzini S, Mattioli G, Disma, N, Jasonni, V: Hirschsprung's 
disease: What about mortality? Pediatr Surg Int, 27(5): 473-478, 2011 
Polley, TZ Jr, Coran AG, Wesley JR: A ten-year experience with ninety-two cases of 
hirschsprung's disease. including sixty-seven consecutive endorectal pull-through 
procedures. Ann Surg , 202(3): 349-355, 1985  
Porokuokka LL, Virtanen HT, Lindén J, Sidorova Y, Danilova T, Lindahl M, Saarma 
M, Andressoo JO: Gfra1 Underexpression Causes Hirschsprung’s Disease and 
Associated Enterocolitis in Mice. Cell Mol Gastroenterol Hepatol , In press, 2018  
Rao M and Gershon MD: The bowel and beyond: the enteric nervous system in 
neurological disorders. Nat Rev Gastroenterol Hepatol , 13(9): 517–528, 2016 
Rao M and Gershon MD: Enteric nervous system development: What could possibly go 
wrong? Nat Rev.Neurosci, 19(9): 552-565, 2018 
Rhodes JM, Black RR, Gallimore R, Savage A: Histochemical demonstration of 
desialation and desulphation of normal and inflammatory bowel disease rectal mucus by 
faecal extracts. Gut, 26(12): 1312-1318, 1985  
 58 
 
Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M: Renal agenesis and 
the absence of enteric neurons in mice lacking GDNF. Nature, 382(6586): 70-73, 1996 
Schill EM, Lake JI, Tusheva OA, Nagy N, Bery SK, Foster L, . . . Heuckeroth RO: 
Ibuprofen slows migration and inhibits bowel colonization by enteric nervous system 
precursors in zebrafish, chick and mouse. Dev Biol, 409(2): 473-488, 2016 
Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V: Defects in the 
kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret. 
Nature, 367(6461): 380-383, 1994 
Schütte A, Ermund A, Becker-Pauly C, Johansson ME, Rodriguez-Pineiro AM, 
Bäckhed F, Müller S, Lottaz D, Bond JS and Hansson GC: Microbial-induced meprin β 
cleavage in MUC2 mucin and a functional CFTR channel are required to release 
anchored small intestinal mucus. Proc Natl Acad Sci U S A, 111(34): 12396-401, 2014 
Sender R, Fuchs S, Milo R: Revised estimates for the number of human and bacteria 
cells in the body. PLoS Biology, 14(8): 2016 
Sharkey KA and Savidge TC2014: Role of enteric neurotransmission in host defense 
and protection of the gastrointestinal tract. Auton Neurosci, 181: 94-106, 2014 
Southard-Smith EM, Kos L, Pavan WJ: Sox10 mutation disrupts neural crest 
development in dom hirschsprung mouse model. Nat Genet, 18(1): 60-64, 1998 
Spencer N, Walsh M, Smith TK: Does the guinea-pig ileum obey the 'law of the 
intestine'? J Physiol, 517: 889-898, 1999 
Srinivasan S, Anitha M, Mwangi S, Heuckeroth RO: Enteric neuroblasts require the 
phosphatidylinositol 3-kinase/akt/forkhead pathway for GDNF-stimulated survival. Mol 
Cell Neurosci , 29(1): 107-119, 2005 
Stewart DR and von Allmen D: The genetics of hirschsprung disease. Gastroenterol 
Clin North Am , 32(3): 819-37, 2003 
Taraviras S, Marcos-Gutierrez CV, Durbec P, Jani H, Grigoriou M, Sukumaran M, . . . 
Pachnis V: Signalling by the RET receptor tyrosine kinase and its role in the 
development of the mammalian enteric nervous system. Development, 126(12): 2785-
2797, 1999 
Thiagarajah JR, Yildiz H, CarlsonT, Thomas AR, Steiger C, Pieretti A, Goldstein AM: 
Altered goblet cell differentiation and surface mucus properties in hirschsprung disease. 
PloS One, 9(6): 2014 
Tobisawa Y, Imai Y, Fukuda M, Kawashima H: Sulfation of colonic mucins by N-
acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental 
colitis in mice. J Biol Chem, 285(9): 6750-6760, 2010 
Uesaka T, Nagashimada M, Enomoto H: GDNF signaling levels control migration and 
neuronal differentiation of enteric ganglion precursors. J Neurosci, 33(41): 16372-
16382, 2013 
 59 
 
Wendelschafer-Crabb G, Neppalli V, Jessurun J, Hodges J, Vance K, Saltzman D, . . . 
Kennedy WR: Mucosal nerve deficiency in chronic childhood constipation: A 
postmigration defect? J Ped Surg, 44(4): 773-782, 2009 
Wu JJ, Chen JX, Rothman TP, Gershon MD: Inhibition of in vitro enteric neuronal 
development by endothelin-3: Mediation by endothelin B receptors. Development, 
126(6): 1161-1173, 1999  
Yntema CL and Hammond WS: The origin of intrinsic ganglia of trunk viscera from 
vagal neural crest in the chick embryo. J Comp Neurolol, 101(2): 515-541, 1954  
Yoo BB and Mazmanian SK: The enteric network: Interactions between the immune 
and nervous systems of the gut. Immunity, 46(6): 910-926, 2017 
Young HM, Bergner AJ, Anderson RB, Enomoto H, Milbrandt J, Newgreen DF, 
Whitington PM: Dynamics of neural crest-derived cell migration in the embryonic 
mouse gut. Dev Biol, 270(2): 455-473, 2004 
Young HM and Newgreen D: Enteric neural crest-derived cells: Origin, identification, 
migration, and differentiation. Anat Rec., 262(1): 1-15, 2001 
Zhao L, Dhall D, Cheng Z, Wang HL, Doherty TM, Bresee C, Frykman PK: Murine 
model of hirschsprung-associated enterocolitis II: Surgical correction of aganglionosis 
does not eliminate enterocolitis. J Ped Surg, 45(1): 206-11, 2010 
 
 
 
 
 
 
 
 
  
 
 
  
